Business

Private Equity Pumps INR 4,900 Crore into Indian Healthcare in Q2 CY25 Across 33 Deals

Although the deal volume dipped by 21% compared to the previous quarter, the overall investment value saw a modest 3% increase, making Q2 CY25 the second-highest quarter by value since Q2 CY24. The uptick was largely driven by a few mid-sized, high-confidence transactions, particularly in pharma manufacturing and hospital chains.

• By Newsdesk
• New Delhi
• Jul 17, 2025

Business

India’s healthcare sector attracted private equity (PE) investments worth ₹4,900 crore ($580 million) through 33 deals in the second quarter of calendar year 2025, spanning hospitals, pharmaceuticals, healthtech, and wellness, according to a report by Grant Thornton Bharat.

Although the deal volume dipped by 21% compared to the previous quarter, the overall investment value saw a modest 3% increase, making Q2 CY25 the second-highest quarter by value since Q2 CY24. The uptick was largely driven by a few mid-sized, high-confidence transactions, particularly in pharma manufacturing and hospital chains.

“PE activity this quarter was concentrated around institutional-grade platforms with strong fundamentals and IPO readiness, particularly in pharma and healthcare delivery,” the report stated.

HealthTech emerged as the most active sub-sector, accounting for 10 of the 33 deals, followed by wellness (7), pharmaceuticals (5), medical devices (5), and hospitals (4).

Among the largest transactions was a $218 million (approx. ₹18,500 crore) seed investment by U.S.-based General Catalyst in PB Healthcare. Another significant deal was Advent International’s $175 million investment in Felix Pharma for a sizable minority stake.

“Pharma and biotech led the quarter in deal value, supported by strategic cross-border moves and growth capital infusion,” said Bhanu Prakash, Partner and Healthcare Services Industry Leader at Grant Thornton Bharat. “Meanwhile, hospitals and digital health platforms are charting distinct and scalable growth trajectories.”

Looking ahead, Prakash noted that the sector is likely to witness sharper and more targeted investments in the latter half of the year, particularly as preventive care and digital health continue to gain momentum.

The sustained interest underscores the healthcare sector’s evolving landscape, with investors zeroing in on scalable, tech-enabled platforms with long-term potential.

(With inputs from The Economic Times)